Cell line-based model systems only resemble the clinical situation to a certain extent; therefore, six PDX models of adult ALL patients with KMT2A rearrangements (KMT2A-r) or BCR::ABL1 translocation were selected and VEN-treated with the same schedule as the cell line-based models. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.